Synergistic effect of concurrent high molecular risk mutations and lower JAK2 mutant variant allele frequencies on prognosis in patients with myelofibrosis-insights from a multicenter study.
Wang YH, Wei CH, Lin CC, Gurnari C, Awada H, Benajiba L, Daltro de Oliveira R, Soret-Dulphy J, Cassinat B, Zucenka A, Mosquera Orgueira A, Yuan CT, Lee SH, Yao CY, Gurashi K, Hou HA, Batta K, Pérez Encinas MM, Chou WC, Maciejewski JP, Wiseman DH, Kiladjian JJ, Tien HF.
Wang YH, et al. Among authors: lee sh.
Leukemia. 2025 Jan;39(1):144-154. doi: 10.1038/s41375-024-02422-4. Epub 2024 Oct 4.
Leukemia. 2025.
PMID: 39367172